BioSpace News Archive

Hemogenyx Pharmaceuticals PLC Announces Development Agreement - Autoimmune Disease Treatments

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has signed a Biological Investigation and Material Supply Agreement (“Agreement”) with a leading global pharmaceutical company (“GlobalCo”) engaged in the research, development, manufacture and marketing of pharmaceutical products.

June 26, 2020
·
3 min read
BioForest

Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar

Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, today announced that it will receive a royalty from Pfizer related to sales of a rituximab biosimilar product, RUXIENCE®

June 26, 2020
·
4 min read
AllStar Health Brands Inc., (ALST) Announces Covid-19 Test Kit Import Permit for Sales into Peru

AllStar Health Brands Inc. (OTC PINK:ALST) a specialty pharmaceutical and nutritional supplements company is pleased to announce that through one of its network of Distributors has obtained a Covid-19 Rapid Antibody Test Import Permit for Peru.

June 26, 2020
·
2 min read
Business

CSOFT Joins Pharmaceutical and Biotech Leaders at First Virtual DIA

CSOFT Health Sciences, a leading provider of cross-border medical communications solutions, is pleased to announce Senior VP Dr. Nimita Limaye’s role as the new Regional Chair of DIA’s India Medical Writing Community

June 26, 2020
·
2 min read